Testicular cancer incidence in eight Northern European countries: Secular and recent trends

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 12, 2004, Pages 2157-2166

  Richiardi, Lorenzo ^a,c,l   Bellocco, Rino ^a   Adami, Hans Olov ^a   Torrång, Anna ^a   Barlow, Lotti ^b   Hakulinen, Timo ^d   Rahu, Mati ^e,f   Stengrevics, Aivars ^g   Storm, Hans ^h   Tretli, Steinar ⁱ   Kurtinaitis, Juozas ^j   Tyczynski, Jerzy E ^k   Akre, Olof ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b CENTRE FOR EPIDEMIOLOGY   (Sweden)

^c UNIVERSITY OF TURIN   (Italy)

^d FINNISH CANCER REGISTRY   (Finland)

^e Institute of Experimental and Clinical Medicine Tallinn   (Estonia)

^f Estonian Centre of Behavioral and Health Sciences   (Estonia)

^g RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^h DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

ⁱ CANCER REGISTRY OF NORWAY   (Norway)

^j VILNIUS UNIVERSITY   (Lithuania)

^k INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^l Unit of Cancer Epidemiology   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; COHORT ANALYSIS; DATA ANALYSIS; DENMARK; ESTONIA; EUROPE; FINLAND; GEOGRAPHIC DISTRIBUTION; HUMAN; LATVIA; LITHUANIA; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; NORWAY; POLAND; POPULATION RESEARCH; PRIORITY JOURNAL; SEMINOMA; SWEDEN; TESTIS CANCER;

ADOLESCENT; ADULT; AGE FACTORS; EPIDEMIOLOGIC STUDIES; EUROPE; GEOGRAPHY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 19944428732     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Møller H. Trends in incidence of testicular cancer and prostate cancer in Denmark. Hum Reprod 2001;16:1007-11.
2. Adami H-O, Bergström R, Möhner M, et al. Testicular cancer in nine northern European countries. Int J Cancer 1994;59:33-8.
3. Wanderås EH, Tretli S, Fosså SD. Trends in incidence of testicular cancer in Norway 1955-1992. Eur J Cancer 1995;31A:2044-8.
4. Boyle P, Kaye SB, Robertson AG. Changes in testicular cancer in Scotland. Eur J Cancer Clin Oncol 1987;23:827-30.
5. Power DA, Brown RS, Brock CS, et al. Trends in testicular carcinoma in England and Wales, 1971-99. BJU Int 2001;87:361-5.
6. dos Santos Silva I, Swerdlow AJ, Stiller CA, et al. Incidence of testicular germ-cell malignancies in England and Wales: trends in children compared with adults. Int J Cancer 1999;83:630-4.
7. Liu S, Semenciw R, Waters C, et al. Clues to the aetiological heterogeneity of testicular seminomas and non-seminomas: time trends and age-period-cohort effects. Int J Epidemiol 2000;29:826-31.
8. Weir HK, Marrett LD, Moravan V. Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996. CMAJ 1999;160:201-5.
9. Pearce N, Sheppard RA, Howard JK, et al. Time trends and occupational differences in cancer of the testis in New Zealand. Cancer 1987;59:1677-82.
10. Stone JM, Cruickshaak DG, Sandeman TF, et al. Trebling of the incidence of testicular cancer in Victoria, Australia (1950-1985). Cancer 1991;68:211-9.
11. Zheng T, Holford TR, Ma Z, et al. Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935-1992. Int J Cancer 1996;65:723-9.
12. McGlynn KA, Devesa SS, Sigurdson AJ, et al. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003;97:63-70.
13. Levi F, Te VC, Randimbison L, et al. Trends in testicular cancer incidence in Vaud, Switzerland. Eur J Cancer Prev 2003;12:347-9.
14. Bergström R, Adami H-O, Möhner M, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 1996;88:727-33.
15. Tamini R, Adami H-O. Testicular cancer. In: Adami H-O, Hunter D, Trichopoulos D, editors. Textbook of cancer epidemiology. New York: Oxford University Press; 2002. p. 429-45.
16. Møller H. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 1993;23:8-13.
17. Coupland CA, Chilvers CE, Davey G, et al. Risk factors for testicular germ cell tumours by histological tumour type. United Kingdom Testicular Cancer Study Group. Br J Cancer 1999;80:1859-63.
18. Møller H, Skakkebaek NE. Risks of testicular cancer and cryptorchidism in relation to socio-economic status and related factors: case-control studies in Denmark. Int J Cancer 1996;66:287-93.
19. Møller H, Skakkebaek NE. Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control 1997;8:904-12.
20. Moss AR, Osmond D, Bacchetti P, et al. Hormonal risk factors in testicular cancer. A case-control study. Am J Epidemiol 1986;124:39-52.
21. Prener A, Hsieh CC, Engholm G, et al. Birth order and risk of testicular cancer. Cancer Causes Control 1992;3:265-72.
22. Sabroe S, Olsen J. Perinatal correlates of specific histological types of testicular cancer in patients below 35 years of age: a case-cohort study based on midwives' records in Denmark. Int J Cancer 1998;78:140-3.
23. Swerdlow AJ, Huttly SR, Smith PG. Prenatal and familial associations of testicular cancer. Br J Cancer 1987;55:571-7.
24. Swerdlow AJ, Huttly SR, Smith PG. Testicular cancer and antecedent diseases. Br J Cancer 1987;55:97-103.
25. Weir HK, Marrett LD, Kreiger N, et al. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer 2000;87:438-43.
26. Haughey BP, Graham S, Brasure J, et al. The epidemiology of testicular cancer in upstate New York. Am J Epidemiol 1989;130:25-36.
27. Westergaard T, Andersen PK, Pedersen JB, et al. Testicular cancer risk and maternal parity: a population-based cohort study. Br J Cancer 1998;77:1180-5.
28. Richiardi L, Akre O, Lambert FA, et al. Birth order, sibship size and risk for germ-cell testicular cancer. Epidemiology 2004;15:323-9.
29. Møller H, Skakkebaek NE. Risk of testicular cancer in subfertile men: case-control study. BMJ 1999;318:559-62.
30. Richiardi L, Akre O, Bellocco R, et al. Perinatal determinants of germ-cell testicular cancer in relation to histological subtypes. Br J Cancer 2002;87:545-50.
31. Garner MJ, Birkett NJ, Johnson KC, et al. Dietary risk factors for testicular carcinoma. Int J Cancer 2003;106:934-41.
32. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. 7. IARC Sci Publ No. 143. Lyon: IARC Press; 1997.
33. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents, Vol. 8. IARC Sci Publ No. 155. Lyon: IARC Press; 2003.
34. Storm H, Clemmensen I, Black R. Survey of cancer registries in the European Union. IARC Technical Report No. 28. Lyon: IARC Press; 1998.
35. Aareleid T, Mägi M. Vähihaigestumus Eestis 2000: cancer incidence in Estonia 2000. Tallinn: Estonian Cancer Registry; 2003.
36. Zatonski W, Tyczynski, J. Cancer in Poland in 1996. Warsaw: Center of Oncology; 1999.
37. Association of Nordic Cancer Registries. Survey of Nordic Cancer Registries: Danish Cancer Society; 2000 [cited 2004 Jun 18]. Available from: http://ncu.cancer.dk/ancr.
38. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I. Age-period and age-cohort models. Stat Med 1987;6:449-67.
39. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II. Age-period-cohort models. Stat Med 1987;6:469-81.
40. Osmond C, Gardner MJ. Age, period and cohort models applied to cancer mortality rates. Stat Med 1982;1:245-59.
41. Pugh RCB. Pathology of the testes. Oxford: Blackwell Scientific Publications; 1976.
42. Mostofi FK, Sobin LH. International histological typing of testes tumor (No. 16). Geneva: WHO; 1977.
43. Rajpert-De Meyts E, Jørgensen N, Brøndum-Nielsen K, et al. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS 1998;106:198-204.
44. Moger TA, Aalen OO, Halvorsen TO, et al. Frailty modeling of testicular cancer incidence using Scandinavian data. Biometrics 2004;5:1-14.
45. Ekbom A, Richiardi L, Akre O, et al. Age at immigration and duration of stay in relation to risk for testicular cancer among Finnish immigrants in Sweden. J Natl Cancer Inst 2003;95:1238-40.
46. Parkin DM, Iscovich J. Risk of cancer in migrants and their descendants in Israel. II. Carcinomas and germ-cell tumours. Int J Cancer 1997;70:654-60.
47. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993;341:1392-5.
48. Petridou E, Roukas KI, Dessypris N, et al. Baldness and other correlates of sex hormones in relation to testicular cancer. Int J Cancer 1997;71:982-5.
49. Wanderås EH, Grotmol T, Fosså SD, et al. Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer, a prospective population- and register-based study on Norwegian males born between 1967 and 1995. Cancer Causes Control 1998;9:475-86.
50. Depue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 1983;71:1151-5.
51. Brown LM, Pottern LM, Hoover RN. Prenatal and perinatal risk factors for testicular cancer. Cancer Res 1986;46:4812-6.
52. Dieckmann KP, Endsin G, Pichlmeier U. How valid is the prenatal estrogen excess hypothesis of testicular germ cell cancer? A case control study on hormone-related factors. Eur Urol 2001;40:677-83.
53. Schottenfeld D. Testicular cancer. In: Shottenfeld D, Fraumeni FJ, editors. Cancer epidemiology and prevention. New York: Oxford University Press; 1996. p. 1207-19.
54. Clemmesen J. Is pregnancy smoking causal to testis cancer in sons? A hypothesis. Acta Oncol 1997;36:59-63.
55. Pettersson A, Kaijser M, Richiardi L, et al. Women smoking and testicular cancer: one epidemic causing another? Int J Cancer 2004;109:941-4.
56. Jacobsen R, Bostofte E, Engholm G, et al. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ 2000;321:789-92.
57. United Kingdom Testicular Cancer Study Group. Aetiology of testicular cancer, association with congenital abnormalities, age at puberty, infertility, and exercise. BMJ 1994;308:1393-9.
58. Richiardi L, Akre O, Montgomery SM, et al. A. Fecundity and twinning rates as measures of fertility before diagnosis of germ-cell testicular cancer. J Natl Cancer Inst 2004;96:145-7.
59. Weir HK, Kreiger N, Marrett LD. Age at puberty and risk of testicular germ cell cancer (Ontario, Canada). Cancer Causes Control 1998;9:253-8.
60. Richiardi L, Askling J, Granath F, et al. Body size at birth and adulthood and the risk for germ-cell testicular cancer. Cancer Epidemiol Biomarkers Prev 2003;12:669-73.
61. Rasmussen F, Gunnell D, Ekbom A, et al. Birth weight, adult height, and testicular cancer: cohort study of 337,249 Swedish young men. Cancer Causes Control 2003;14:595-8.
62. Dieckmann KP, Pichlmeier U. Is risk of testicular cancer related to body size? Eur Urol 2002;42:564-9.
63. Gallagher RP, Huchcroft S, Phillips N, et al. Physical activity, medical history, and risk of testicular cancer (Alberta and British Columbia, Canada). Cancer Causes Control 1995;6:398-406.
64. Ganmaa D, Li XM, Wang J, et al. Incidence and mortality of testicular and prostatic cancers in relation to world dietary practices. Int J Cancer 2002;98:262-7.
65. Davies TW, Palmer CR, Ruja E, et al. Adolescent milk, dairy product and fruit consumption and testicular cancer. Br J Cancer 1996;74:657-60.
66. Sigurdson AJ, Chang S, Annegers JF, et al. A case-control study of diet and testicular carcinoma. Nutr Cancer 1999;34:20-6.
67. Danish Cancer Registry. Incidence of cancer in Denmark, 1973-77. Copenhagen: Danish Cancer Society; 1982.
68. American Cancer Society. Manual of tumor nomenclature and coding. New York: American Cancer Society; 1968.
69. Percy C, Van Holten V, Muir C. International classification of diseases for oncology. 2nd ed. Geneva: WHO; 1990.
70. American Cancer Society. Manual of tumor nomenclature and coding. New York: American Cancer Society; 1951.